Profile
Richard Seabrook is currently the Head of Business Development at Wellcome Trust Technology Transfer since 1998.
He previously worked as a Non-Executive Director at ProXara Biotechnology Ltd., Director at Acesion Pharma ApS, and Commercial Manager at Quadrant Healthcare Plc.
Richard Seabrook active positions
| Companies | Position | Start |
|---|---|---|
Wellcome Trust Technology Transfer
Wellcome Trust Technology Transfer Investment ManagersFinance Wellcome Trust Technology Transfer invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It provides capital for venture debt and early and later stage capital requirements. | Corporate Officer/Principal | 01/01/1998 |
Former positions of Richard Seabrook
| Companies | Position | End |
|---|---|---|
Quadrant Healthcare Plc
Quadrant Healthcare Plc Pharmaceuticals: MajorHealth Technology Researches, develops, and formulates drugs | Corporate Officer/Principal | - |
Acesion Pharma ApS
Acesion Pharma ApS Miscellaneous Commercial ServicesCommercial Services Develops and manufactures antiarrhythmic drugs for treatment of atrial fibrillation | Director/Board Member | - |
ProXara Biotechnology Ltd.
ProXara Biotechnology Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of cancer | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Wellcome Trust Technology Transfer
Wellcome Trust Technology Transfer Investment ManagersFinance Wellcome Trust Technology Transfer invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It provides capital for venture debt and early and later stage capital requirements. | Finance |
Quadrant Healthcare Plc
Quadrant Healthcare Plc Pharmaceuticals: MajorHealth Technology Researches, develops, and formulates drugs | Health Technology |
ProXara Biotechnology Ltd.
ProXara Biotechnology Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of cancer | Health Technology |
Acesion Pharma ApS
Acesion Pharma ApS Miscellaneous Commercial ServicesCommercial Services Develops and manufactures antiarrhythmic drugs for treatment of atrial fibrillation | Commercial Services |
- Stock Market
- Insiders
- Richard Seabrook
















